Exercise and Systemic Lupus Erythematosus
NCT01515163 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2016-01-13
Summary
The investigators hypothesize that a three-month aerobic exercise training program will positively affect the lipid profile, insulin sensitivity , cytokine profile, the cardiovascular parameters and muscle strength in SLE patients.
Conditions
Interventions
- BEHAVIORAL
-
Exercise training
Aerobic exercise training, two times a week
Sponsors & Collaborators
-
University of Sao Paulo
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 7 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2015-07-31
- Completion
- 2016-07-31
Countries
- Brazil
Study Locations
More Related Trials
-
Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus
NCT06166199 ·Status: RECRUITING ·Phase: NA
-
Type 1 Interferon Induced Changes to Exercise Adaptations in Systemic Lupus Erythematosus Patients
NCT05478018 ·Status: COMPLETED ·Phase: NA
-
Activity and Nutrition Trial in Lupus to Energize and Renew
NCT02281513 ·Status: COMPLETED ·Phase: NA
-
Systemic Lupus Erythematosus
NCT05984316 ·Status: RECRUITING ·Phase: NA
-
Respiratory Function, Physical Activity and Fatigue in SLE
NCT07193745 ·Status: COMPLETED
-
Water-based Liuzijue Exercise on Childhood-onset Systemic Lupus Erythematosus
NCT07024082 ·Status: COMPLETED ·Phase: NA
-
Exercise and Nutrition Recommendations for Patients Using Glucocorticoids (ENRG)
NCT05090189 ·Status: UNKNOWN ·Phase: NA
-
Effects of an Intervention With EVOO and Physical Activity in Patients With Systemic Lupus Erythematosus
NCT05261529 ·Status: UNKNOWN ·Phase: NA
-
Reducing Depressive Symptoms in Systemic Lupus Erythematosus
NCT01120652 ·Status: COMPLETED ·Phase: NA
-
Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment
NCT07102030 ·Status: RECRUITING
-
Efficacy and Safety of Belimumab in SLE Patients
NCT04515719 ·Status: COMPLETED ·Phase: PHASE4
-
Lupus Intervention for Fatigue Trial
NCT02653287 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
NCT04276701 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Development and Evaluation of Modified Yoga in Systemic Lupus Erythematosus (SLE)
NCT01176643 ·Status: COMPLETED ·Phase: NA
-
Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE)
NCT00997100 ·Status: COMPLETED ·Phase: PHASE2
-
Laser Puncture and Program of Lifestyle Modification in Lupus Females
NCT05381545 ·Status: UNKNOWN ·Phase: NA
-
Relation of Antibodies Against Oxidized Low Density Lipoproteins to Disease Activity and Cardiovascular Affection in Systemic Lupus.
NCT05479071 ·Status: UNKNOWN
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Improving Quality of Life for African American Female Adolescents With Lupus
NCT00068874 ·Status: COMPLETED ·Phase: PHASE2
-
Haematological Indices in Systemic Lupus Erythematosus
NCT04110184 ·Status: UNKNOWN
-
Pulmonary Disease Among Patients With Systemic Lupus Erythematosus
NCT06087523 ·Status: ENROLLING_BY_INVITATION
-
Premature Atherosclerosis in Systemic Lupus Erythematosus
NCT04037293 ·Status: UNKNOWN
-
Interleukin23 in Systemic Lupus
NCT06713187 ·Status: RECRUITING ·Phase: NA
-
Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus
NCT01629784 ·Status: COMPLETED ·Phase: NA
-
New Signaling Pathway Targeting Systemic Lupus Erythematosus
NCT03984227 ·Status: UNKNOWN